Pediatric Diffuse Midline Gliomas H3 K27M-Mutant and Non-Histone Mutant Midline High-Grade Gliomas in Neurofibromatosis Type 1 in Comparison With Non-Syndromic Children: A Single-Center Pilot Study
Background: Pediatric neurofibromatosis type 1 (NF1) patients rarely develop aggressive central nervous system tumors. Among high-grade gliomas (HGGs), histone mutant diffuse midline gliomas (DMGs H3 K27M-mutant) have exceptionally been reported. The aim of this retrospectives single-center study wa...
Main Authors: | Federica Garibotto, Francesca Madia, Claudia Milanaccio, Antonio Verrico, Arnoldo Piccardo, Domenico Tortora, Gianluca Piatelli, Maria Cristina Diana, Valeria Capra, Maria Luisa Garrè, Andrea Rossi, Giovanni Morana |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00795/full |
Similar Items
-
Mosaic Pattern of H3 K27M-Mutant Protein Expression in a Diffuse Midline Glioma—A Diagnostic Dilemma for the Pathologist
by: Deepti Narasimhaiah, et al.
Published: (2021-05-01) -
Diffuse midline glioma-H3K27M mutant. A novel entity with a defining and specific IHC marker
by: Prachi Agarwal, et al.
Published: (2021-01-01) -
Exploiting Gangliosides for the Therapy of Ewing’s Sarcoma and H3K27M-Mutant Diffuse Midline Glioma
by: Arthur Wingerter, et al.
Published: (2021-01-01) -
Current knowledge on the immune microenvironment and emerging immunotherapies in diffuse midline glioma
by: Gabrielle Price, et al.
Published: (2021-07-01) -
Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant
by: Rouzbeh Banan, et al.
Published: (2017-12-01)